RAD Biomed invests in early-stage digital health and medical device Israel based ventures
We seek out companies with disruptive new solutions to real-world challenges and unmet needs
Come join our strong community of entrepreneurs, benefit from our in-house, multidisciplinary capabilities and enjoy long-term support
Radiaction has received an additional 510(k) Clearance from the Food and Drug Administration (FDA) for its Radiation Shielding System
FEMSelect, developer of EnPlace®, a minimally invasive, meshless approach to pelvic floor ligament fixation, completed its US$9M Series B funding
The RAD Group is a group of independent companies that develop, manufacture and market solutions for diverse segments of the networking and telecommunications industry. The RAD Group has been named "the most fertile ground" for developing Israeli entrepreneurs, having already produced 56 "serial entrepreneurs."
The RAD Group has decades of experience in guiding and nurturing startups as they grow towards commercial launch, sales growth and successful exit, (9 Nasdaq IPOs and 10 M&As).
RAD BioMed’s co-founders, Mr. Yehuda Zisapel and Prof. Nava Zisapel, also co-founded
Neurim Pharmaceutical Ltd.
The RAD Group